Cell Signaling Technology

FosB (5G4) Rabbit Monoclonal Antibody (BSA and Azide Free)

#32170 · $865

18
Citing papers
428
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation3Cancer-related molecular mechanisms research2Circular RNAs in diseases2Head and Neck Cancer Studies2Lung Cancer Treatments and Mutations2Hippo pathway signaling and YAP/TAZ2Cancer Cells and Metastasis1BRCA gene mutations in cancer1

Papers citing this product

1
Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin
International Journal of Molecular Medicine·2016·65 cit.·DOI
2
miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer
BMC Cancer·2017·63 cit.·DOI
3
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
Cancers·2020·60 cit.·DOI
4
Adaptive ERK signalling activation in response to therapy and in silico prognostic evaluation of EGFR-MAPK in HNSCC
British Journal of Cancer·2020·50 cit.·DOI
5
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer
PLoS ONE·2015·49 cit.·DOI
6
Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma
Cells·2023·40 cit.·DOI
7
Dominant-negative ATF5 rapidly depletes survivin in tumor cells
Cell Death and Disease·2019·22 cit.·DOI
8
IL-27 Mediates Pro-Inflammatory Effects via the ERK Signaling Pathway During Preterm Labor
Frontiers in Immunology·2021·16 cit.·DOI
9
The ezh2(sa1199) mutant zebrafish display no distinct phenotype
PLoS ONE·2019·12 cit.·DOI
10
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
Cancers·2021·12 cit.·DOI

Similar products

ProductVendorPricePapers
FosB AntibodyRabbitCell Signaling Technology$317200
FosB (5G4) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$152100